author-photo

K. Nakagawa

Kindai University

220

Papers

3243

Citations

Citation Trend

Filter By

Papers (145) Sort By

Journal Conference Others

139PD Patient-reported outcomes from FLAURA: Osimertinib versus standard of care (SoC) epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) in patients with EGFR-mutated advanced non-small cell lung cancer (NSCLC)

2018 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (4)
P1.01-34 Docetaxel Plus Ramucirumab with Prophylactic PEG-G-CSF Support for Chemo-NaïVe Elderly NSCLC Patients: A Phase II Study (WJOG9416L)

2018 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
471PEffect of second-line ramucirumab in east Asian patients with refractory and aggressive disease: Subgroup analysis from REVEL and JVCG trials in non-small cell lung cancer

2018 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
P1.11-07 Utility of the Maximum CT Value in Predicting Invasiveness of Pure GGNs

2018 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
P1.17-06 Salvage Surgery After Chemotherapy and/or Radiotherapy Including SBRT and Proton: Consecutive Analysis of 46 Patients

2018 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
1381PDGefitinib with or without pemetrexed in nonsquamous (NS) non-small cell lung cancer (NSCLC) with EGFR mutation (mut): Final overall survival (OS) results from a randomized phase II study

2018 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (4)
OA02.07 Updated Results of Phase 1 Study of DS-8201a in HER2-Expressing or –Mutated Advanced Non-Small-Cell Lung Cancer

2018 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (20)
P3.01-96 Clinical Characteristics of Non–Small Cell Lung Cancer Harboring Mutations in Exon 20 Of EGFR or HER2

2018 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
OA08.01 Long-Term Efficacy and Safety of Nivolumab in Second- or Third-Line Japanese Malignant Pleural Mesothelioma Patients (Phase II: MERIT Study)

2018 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (6)
LBA5Efficacy and safety of nivolumab (nivo) monotherapy versus chemotherapy (chemo) in recurrent small cell lung cancer (SCLC): Results from CheckMate 331

2018 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (74)